Sofia Lindqvist
Media & Financial Communications Manager
Email: sofia.lindqvist@molnlycke.com
Phone: +4672 255 35 09
Mölnlycke Health Care publishes Annual report for 2024
Gothenburg, Sweden. 1 April 2025. Today Mölnlycke Health Care has published its Annual report for 2024, including the sustainability report.
“Our strong financial position and continued growth allow us to direct our future and continued investments. At the same time, it is clear that our strategy and previous investments have paid off, enabling close relationships with our customers working alongside them to handle the challenges of healthcare today,” says Zlatko Rihter, CEO of Mölnlycke.
Highlights from the year:
- Continued strong growth at 7.4% compared to previous year and annual sales of EUR 2,064 million with improved profitability.
- The progress in becoming a leader in sustainable healthcare was recognised with a platinum medal from EcoVadis.
- Focus on transformation through partnerships commenced in 2024 with the acquisition of P.G.F. Industry Solutions, the strategic partnership with Ondine Biomedical Inc and strategic investments in MediWound and Siren. The joint venture Tamer Mölnlycke Care in Saudi Arabia has started production and there are plans for expansion in India and China.
Download and read the full report on
For more information, please contact:
Latest news
Read all news-
New study demonstrates the potential benefits of dressing regime improvements in delivering value-based chronic wound care
-
Mölnlycke Health Care announces launch of the 2025 Future Summit
Mölnlycke Health Care’s Wound Care business area is delighted to announce the launch of its 2025 Future Summit, an educational event bringing together healthcare professionals (HCPs) from across Europe, the Middle East, and Africa (EMEA).
-
Mölnlycke Health Care reaches 100% renewable electricity target
Mölnlycke, a world leading MedTech company, has secured 100% renewable electricity for all its established and new manufacturing sites and its headquarters, reaching its first near-term SBTi (Science Based Targets initiative)-validated target.
-
Mölnlycke Health Care announces USD 8 million investment in diabetic foot ulcer management system company Siren
-
Mölnlycke Health Care wins Swedish Sustainability Tech award
Mölnlycke is proud to announce that it has been awarded the Capgemini Swedish Sustainability Tech Award 2024 for Mölnlycke ProcedurePak® trays. This accolade recognises the company’s innovative practices and dedication to revolutionise healthcare for people and planet.
-
Mölnlycke Health Care appoints Guillaume Joucla as Chief Financial Officer
Joucla’s extensive experience and insights to drive financial strategy and growth initiatives.
-
Mölnlycke Health Care and Operation Smile help to change people's lives with newly inaugurated cleft care centre in Philippines
The centre is expected to serve 10,000 patients in the region with transformative cleft care in the first three years of operations.
-
Mölnlycke® Health Care and Transdiagen announce research collaboration to drive innovation in wound care
-
Mölnlycke® Health Care acquires P.G.F. Industry Solutions GmbH, the manufacturer of Granudacyn®, a range of solutions for wound cleansing and moisturising
Today, Mölnlycke Health Care, a world leading MedTech company, specialising in wound care and wound management, announces the completion of the acquisition of P.G.F. Industry Solutions GmbH, the Austrian manufacturer of Granudacyn® wound cleansing and moistening solutions.